Stifel Financial’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.91M Buy
53,256
+11,994
+29% +$880K ﹤0.01% 1388
2025
Q1
$4.71M Sell
41,262
-21,520
-34% -$2.46M 0.01% 1218
2024
Q4
$3.16M Sell
62,782
-26,185
-29% -$1.32M ﹤0.01% 1479
2024
Q3
$4.12M Buy
88,967
+20,546
+30% +$951K ﹤0.01% 1310
2024
Q2
$2.22M Sell
68,421
-8,818
-11% -$287K ﹤0.01% 1656
2024
Q1
$1.95M Buy
77,239
+19,595
+34% +$494K ﹤0.01% 1741
2023
Q4
$1.87M Sell
57,644
-1,191
-2% -$38.7K ﹤0.01% 1719
2023
Q3
$1.6M Buy
58,835
+1,422
+2% +$38.7K ﹤0.01% 1738
2023
Q2
$1.28M Buy
57,413
+2,200
+4% +$49K ﹤0.01% 1920
2023
Q1
$1.2M Buy
55,213
+20,515
+59% +$444K ﹤0.01% 1931
2022
Q4
$705K Buy
34,698
+5,792
+20% +$118K ﹤0.01% 2265
2022
Q3
$741K Buy
28,906
+2,958
+11% +$75.8K ﹤0.01% 2168
2022
Q2
$617K Buy
25,948
+2,560
+11% +$60.9K ﹤0.01% 2343
2022
Q1
$527K Buy
23,388
+2,232
+11% +$50.3K ﹤0.01% 2546
2021
Q4
$419K Buy
21,156
+5,810
+38% +$115K ﹤0.01% 2698
2021
Q3
$302K Buy
15,346
+5,073
+49% +$99.8K ﹤0.01% 2900
2021
Q2
$226K Buy
+10,273
New +$226K ﹤0.01% 3068
2021
Q1
Sell
-119,089
Closed -$3.12M 3222
2020
Q4
$3.12M Sell
119,089
-98,725
-45% -$2.58M 0.01% 1113
2020
Q3
$3.79M Sell
217,814
-10,753
-5% -$187K 0.01% 890
2020
Q2
$3.85M Sell
228,567
-10,248
-4% -$172K 0.01% 834
2020
Q1
$2.82M Buy
+238,815
New +$2.82M 0.01% 884
2019
Q4
Sell
-237,987
Closed -$3.33M 3026
2019
Q3
$3.33M Sell
237,987
-29,738
-11% -$415K 0.01% 1020
2019
Q2
$3.04M Sell
267,725
-20,088
-7% -$228K 0.01% 1073
2019
Q1
$3.43M Sell
287,813
-182,176
-39% -$2.17M 0.01% 979
2018
Q4
$6.28M Sell
469,989
-16,296
-3% -$218K 0.02% 672
2018
Q3
$6.85M Buy
486,285
+474,155
+3,909% +$6.68M 0.02% 699
2018
Q2
$188K Buy
12,130
+1,256
+12% +$19.5K ﹤0.01% 2559
2018
Q1
$182K Buy
+10,874
New +$182K ﹤0.01% 2493